Rising non-neuronal mechanisms by which the medication might lead to monoaminergic terminal destruction, in addition to the neuropsychiatric repercussions of the terminal harm also are introduced. Methamphetamine and three,four-methylenedioxymethamphetamine (MDMA) have identical chemical structures and pharmacologic properties when compared with ot